NIKA PHARMACEUTICALS, INC - 29 Apr 2022 Form 4 Insider Report for NIKA PHARMACEUTICALS, INC (NIKA)

Reporting relationship
Secretary, Director, 10%+ Owner
Issuer ticker
NIKA
Reported as of
29 Apr 2022
Net transaction value
+$250,000,000,000
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Mar 2024, 14:11:51 UTC
Prior SEC filing
19 Mar 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Redekop Clifford Paul

Key filing fact

NIKA PHARMACEUTICALS, INC filed Form 4 for NIKA PHARMACEUTICALS, INC (NIKA) on 19 Mar 2024.

Key facts

  • This page summarizes NIKA PHARMACEUTICALS, INC's Form 4 filing for NIKA PHARMACEUTICALS, INC (NIKA).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 19 Mar 2024, 14:11.

Change

  • Previous filing in this sequence was filed on 19 Mar 2024.
  • Current net transaction value: +$250,000,000,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NKPH transaction

Common

Other

Transaction value
$250,000,000,000
Shares
+5,000,000
Change %
Price
$50000.00*
Shares after
5,000,000
Date
29 Apr 2022
Ownership
LLC
Footnotes
F2
NKPH transaction

Common

Other

Transaction value
$0
Shares
+145,000,000
Change %
Price
$0.000000
Shares after
$150,000,000
Date
20 Jul 2022
Ownership
LLC
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

30-1 Forward Split as dividend

Footnote F2

Intermediation Agreement valued at $50,000

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .